These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12766701

  • 1. Ophthalmic cyclosporine (Restasis) for dry eye disease.
    Med Lett Drugs Ther; 2003 May 26; 45(1157):42-3. PubMed ID: 12766701
    [No Abstract] [Full Text] [Related]

  • 2. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
    Morgan RV, Abrams KL.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1043-6. PubMed ID: 1748607
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK, Davidson MG, English RV, Nasisse MP, Jamieson VE, Gerig TM.
    J Am Vet Med Assoc; 1991 Oct 15; 199(8):1039-42. PubMed ID: 1748606
    [Abstract] [Full Text] [Related]

  • 4. Restasis use in the chronic dry eye patient.
    Bataoel A.
    Insight; 2007 Oct 15; 32(3):21. PubMed ID: 17953324
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A dose-ranging clinical trial to assess the safety and efficacy of cyclosporine ophthalmic emulsion in patients with keratoconjunctivitis sicca. The Cyclosporine Study Group.
    Tauber J.
    Adv Exp Med Biol; 1998 Oct 15; 438():969-72. PubMed ID: 9634996
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Perspective, patience, and cyclosporine.
    Bryan GM.
    J Am Vet Med Assoc; 1992 Jan 15; 200(2):136. PubMed ID: 1559863
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM, McGwin G, Liu B, Owsley C, Rosenstiel C.
    Eye Contact Lens; 2008 Jan 15; 34(1):43-5. PubMed ID: 18180683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Integrating restasis into the management of dry eye.
    Pflugfelder SC.
    Int Ophthalmol Clin; 2006 Jan 15; 46(4):101-3. PubMed ID: 17060796
    [No Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
    Ofri R, Lambrou GN, Allgoewer I, Graenitz U, Pena TM, Spiess BM, Latour E.
    Vet J; 2009 Jan 15; 179(1):70-7. PubMed ID: 17950639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O, Baudouin C, Pisella PJ, Brignole F.
    J Fr Ophtalmol; 2003 Apr 15; 26(4):337-43. PubMed ID: 12843889
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Episcleral cyclosporine A implants for the management of unilateral keratoconjunctivitis sicca in an 8-year-old mare.
    Mackenzie CJ, Carslake HB, Robin M, Kent RJ, Malalana F.
    Vet Ophthalmol; 2017 Jan 15; 20(1):79-83. PubMed ID: 26945681
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.